These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 26906526)

  • 1. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
    Temel JS; Abernethy AP; Currow DC; Friend J; Duus EM; Yan Y; Fearon KC
    Lancet Oncol; 2016 Apr; 17(4):519-531. PubMed ID: 26906526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
    Currow D; Temel JS; Abernethy A; Milanowski J; Friend J; Fearon KC
    Ann Oncol; 2017 Aug; 28(8):1949-1956. PubMed ID: 28472437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
    Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
    Katakami N; Uchino J; Yokoyama T; Naito T; Kondo M; Yamada K; Kitajima H; Yoshimori K; Sato K; Saito H; Aoe K; Tsuji T; Takiguchi Y; Takayama K; Komura N; Takiguchi T; Eguchi K
    Cancer; 2018 Feb; 124(3):606-616. PubMed ID: 29205286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome.
    Currow DC; Abernethy AP
    Future Oncol; 2014 Apr; 10(5):789-802. PubMed ID: 24472001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
    Takayama K; Katakami N; Yokoyama T; Atagi S; Yoshimori K; Kagamu H; Saito H; Takiguchi Y; Aoe K; Koyama A; Komura N; Eguchi K
    Support Care Cancer; 2016 Aug; 24(8):3495-505. PubMed ID: 27005463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion.
    Currow DC; Maddocks M; Cella D; Muscaritoli M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
    Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
    Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
    Nishie K; Yamamoto S; Nagata C; Koizumi T; Hanaoka M
    Lung Cancer; 2017 Oct; 112():25-34. PubMed ID: 29191597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
    Naito T; Uchino J; Kojima T; Matano Y; Minato K; Tanaka K; Mizukami T; Atagi S; Higashiguchi T; Muro K; Takayama K; Furuse J; Morishima E; Takiguchi T; Tamura K
    Cancer; 2022 May; 128(10):2025-2035. PubMed ID: 35195274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis.
    Bai Y; Hu Y; Zhao Y; Yu X; Xu J; Hua Z; Zhao Z
    Support Care Cancer; 2017 May; 25(5):1651-1659. PubMed ID: 28074289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
    Zhang H; Garcia JM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
    Graf SA; Garcia JM
    Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia.
    Fonseca GWPD; von Haehling S
    Expert Opin Pharmacother; 2021 May; 22(7):889-895. PubMed ID: 33491505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ
    Nakanishi Y; Higuchi J; Honda N; Komura N
    Nihon Yakurigaku Zasshi; 2021; 156(6):370-381. PubMed ID: 34719572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol.
    Hoon SN; Fyfe K; Peddle-McIntyre CJ; Bowyer S; Hawkins F; Jeffery E; Chih HJ; Creaney J; Nowak A; Brims F
    BMJ Open Respir Res; 2020 Mar; 7(1):. PubMed ID: 32213537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome.
    Dev R; Amano K; Naito T; Del Fabbro E
    Curr Oncol Rep; 2024 Jul; 26(7):762-772. PubMed ID: 38771469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anamorelin for cancer cachexia.
    Nishie K; Sato S; Hanaoka M
    Drugs Today (Barc); 2022 Mar; 58(3):97-104. PubMed ID: 35274629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Currow DC; Skipworth RJ
    Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
    Wakabayashi H; Arai H; Inui A
    J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):14-16. PubMed ID: 33382205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.